Briya

Company Overview

Snapshot

Founded in October 2020 by David Lazerson and Guy Tish, Briya operates with 51–200 employees. The company has raised $17 million across two funding rounds from six investors. In May 2026, Briya appointed Professor Jonathan Samet, MD, MS, as Chief Epidemiologist, reinforcing its commitment to academic rigor in AI-driven clinical research.

Business overview

Briya is transforming medical research by redefining how researchers access, interact with, and extract insights from healthcare data. The company simplifies the fragmented process of data analysis by converging, harmonizing, and standardizing diverse data sources, eliminating the need for complex coding and labor-intensive data cleaning. Its flagship product, AIRE, is a clinical-grade AI research environment that acts as an intelligent virtual research assistant and epidemiologist. AIRE enables seamless exploration and analysis of complex, multi-source medical data through nine purpose-built AI agents, supporting study design, hypothesis testing, trend visualization, and advanced analytics via a natural-language enabled interface. Briya serves the healthcare and life sciences industries, focusing on areas like cancer research, pharmaceuticals, and patient care, while maintaining high standards of privacy and compliance.

Strategic signal

In June 2026, Briya announced free access to its AIRE platform for the global scientific community, signaling a strategic move to broaden adoption and accelerate AI-powered medical research. This initiative aims to foster transparency and collaboration, potentially positioning AIRE as a standard tool for data-driven discovery in healthcare.

Company Intelligence Q&A

What was a key strategic partnership for Briya in 2025?

In September 2025, Briya partnered with Tanner Health to develop new pathways for clinicians and researchers to access meaningful insights, accelerating clinical innovation and improving patient care in the Southern US.

What significant leadership appointment did Briya make in 2026?

In May 2026, Briya appointed Professor Jonathan Samet, MD, MS, as Chief Epidemiologist, aiming to embed academic rigor into its AI-driven clinical research initiatives.

What milestone did Briya achieve regarding patient data in April 2026?

In April 2026, Briya announced that its global data network had expanded to cover over 120 million patient journeys, accelerating AI-driven medical research.

What was a significant product development for Briya in June 2026?

In June 2026, Briya opened free access to AIRE, its AI-powered medical research platform, to the global scientific community, aiming to bring transparency and accelerate discovery.

What was a notable strategic collaboration for Briya in 2024?

In September 2024, MSD, a leading multinational pharmaceutical company, successfully completed a first-of-its-kind strategic collaboration with Briya for innovative real-world evidence (RWE) data analysis projects.